Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00084656
Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00084656
Protocol Section: NCT00084656
Start Identification Module Data
Expand Identification Module Data
Brief Title: Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Official Title: An Extended Dosing Two-phase Study of MDX-010 as Monotherapy or in Combination With Tyrosinasegp100MART-1 Peptides Emulsified With Montanide ISA 51 VG in the Treatment of Subjects With Resected Stage III or Stage IV Melanoma
Acronym: None
Organization: Bristol-Myers Squibb
Organization Class: INDUSTRY
Organization Study ID: CDR0000365467
Secondary IDs
Secondary ID Type Domain Link
P30CA076292 NIH None None
P30CA014089 NIH None None
MCC-15241 OTHER None None
MDX010-16 OTHER None None
NCI-6446 OTHER None None
CA184-016 OTHER BMS httpsreporternihgovquickSearchP30CA014089
Start Status Module Data
Status Verified Date: 2022-04
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Bristol-Myers Squibb
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Bristol-Myers Squibb
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload